The Drug-Induced Respiratory Disease Website and App

Status post-hematopoietic stem cell (HSCT) or bone marrow transplantation (BMT)

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

II.a

Pulmonary edema, noncardiogenic (NCPE)

Publications

Mancuzo EV, Neves MA, Bittencourt H, de Rezende NA

[Non-infectious pulmonary complications after the hematopoietic stem cell transplantation].

Revista portuguesa de pneumologia. 2010;16(5):815-28

Khurshid I, Anderson LC

Non-infectious pulmonary complications after bone marrow transplantation.

Postgraduate medical journal. 2002;78(919):257-62

Ravenel JG, Scalzetti EM, Zamkoff KW

Chest radiographic features of engraftment syndrome.

Journal of thoracic imaging. 2000;15(1):56-60

Marín D, Berrade J, Ferra C, Mateu A, Berlanga J, Salar A, Torrado H, Grañena A, Ventura JL

Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation.

Intensive care medicine. 1998;24(7):732-5